Targeting cannabinoid 1 and delta opioid receptor heteromers alleviates chemotherapy-induced neuropathic pain S Sierra, A Gupta, I Gomes, M Fowkes, A Ram, EN Bobeck, LA Devi ACS pharmacology & translational science 2 (4), 219-229, 2019 | 43 | 2019 |
Isoniazid and rifampicin as therapeutic regimen in the current era: a review S Somasundaram, A Ram, L Sankaranarayanan Journal of Tuberculosis Research 2014, 2014 | 37 | 2014 |
GPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, But Not Female Mice A Ram, T Edwards, A McCarty, L Afrose, MV McDermott, E Bobeck Frontiers in Pain Research 2 (695396), 2021 | 13 | 2021 |
High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics M Lemos Duarte, NA Trimbake, A Gupta, C Tumanut, X Fan, C Woods, ... Communications biology 4 (1), 238, 2021 | 8 | 2021 |
Morphine‐induced kinase activation and localization in the periaqueductal gray of male and female mice A Ram, TM Edwards, A McCarty, MV McDermott, EN Bobeck Journal of Neurochemistry 159 (3), 590-602, 2021 | 7 | 2021 |
The periaqueductal grey in opioid tolerance and chronic pain A Ram Utah State University, 2021 | 1 | 2021 |
A small molecule ligand for the novel pain target, GPR171, produces minimal reward in mice MV McDermott, A Ram, MT Mattoon, EE Haderlie, MC Raddatz, ... Pharmacology Biochemistry and Behavior 224, 173543, 2023 | | 2023 |
A new therapeutic target for chronic pain: GPR171 agonism reduces chronic neuropathic and inflammatory pain A Ram, TM Edwards, A McCarty, L Afrose, M McDermott, EN Bobeck The FASEB Journal 36, 2022 | | 2022 |
Protein Kinase‐C Inhibition Within the Periaqueductal Gray Counteracts the Development of Morphine Antinociceptive Tolerance A Ram, M McDermott, L Afrose, T Edwards, A McCarty, E Bobeck The FASEB Journal 35, 2021 | | 2021 |
Sex differences in MAP kinase activation in the periaqueductal gray after morphine treatment A McCarty, A Ram, MV McDermott, EN Bobeck The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
Sex Differences in Periaqueductal Gray Kinase Activation After Morphine Tolerance A Ram, TM Edwards, A McCarty, EN Bobeck The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
Role of novel receptor GPR171 in chemotherapy‐induced neuropathic pain TM Edwards, A Ram, A McCarty, EN Bobeck The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
Morphine Induces Differential Activation and Cellular Localization of Protein Kinases in the Mouse Periaqueductal Gray A Ram, T Edwards, EN Bobeck The FASEB Journal 33 (S1), 498.13-498.13, 2019 | | 2019 |
The Interleukin-6 Receptor IL-6R is Expressed in Taste Bud Derived Cell Lines M Kepas, A Ram, TA Gilbertson CHEMICAL SENSES 43 (4), E69-E69, 2018 | | 2018 |
The Role of the Neuropeptide Receptor System, BigLEN-GPR171, in Opioid Reward and Withdrawal L Alfrose, M McDermott, A Ram, L Wilkes, LA Devi, EN Bobeck | | 2018 |
Differential Activation and Cellular Localization of Protein Kinases in the Periaqueductal Gray Following Morphine Treatment A Ram, EN Bobeck | | 2018 |